FDA Finally Admits Johnson and Johnson Vaccine Is Linked To Rare, Incurable Nerve Disorder

Despite all the evidence, it took the Biden administration months to concede that COVID may have come from a lab.

Finally, the FDA has admitted that the Johnson & Johnson vaccination may be connected to Guillain-Barre syndrome, a rare and incurable condition.

The following is taken from FOX News:

The FDA has issued a new warning on the Johnson & JohnsonCOVID-19vaccine and a probable link to Guillain-Barré syndrome, a rare autoimmune nerve illness. The CDC changed the fact sheets that came with the vaccine to indicate an increased risk of the disorder after inoculation.

The FDA issued the warning after receiving approximately 100 preliminary reports of Guillain-Barré syndrome cases against a backdrop of approximately 12.5 million Johnson & Johnson doses administered, according to a statement released Monday. 95 of the instances were serious enough to require hospitalization, with one death reported. The FDA, on the other hand, refrained from establishing a link between the vaccine and the unusual illness.

Are they the real deal?

This vaccination has the potential to cause an incurable condition, but we still think you should have it?

That’s like saying, “Your Bungie is frayed and there’s a 100-foot drop ahead of you, but we still think you should jump!” What the hell is going on here?

The Mayo Clinic contains some information about Guillain-Barre syndrome.

Follow @WeLoveTrump on Telegram.

Guillain-Barre syndrome (gee-YAH-buh-RAY) is an uncommon condition in which your immune system destroys your nerves. The earliest signs and symptoms are usually weakness and tingling in the extremities.

These sensations can spread swiftly, paralyzing your entire body. Guillain-Barre syndrome is a medical emergency in its most severe form.

The majority of persons with this ailment need to be admitted to the hospital for treatment.

Guillain-Barre syndrome’s actual cause is unknown. However, two-thirds of patients have had signs of an infection in the preceding six weeks. Infections of the respiratory or gastrointestinal tract, as well as the Zika virus, are among them.

Guillain-Barre syndrome has no known cure, however some therapies can alleviate symptoms and shorten the illness’s duration. Despite the fact that most people recover from Guillain-Barre syndrome, the death rate ranges from 4% to 7%. At six months, 60-80 percent of persons are able to walk. It may cause side symptoms such as weakness, numbness, or weariness in patients.